Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Hair follicle cells change their DNA packaging during growth cycles and when grown in the lab.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Removing part of the vitamin D receptor stops vitamin D from working properly.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.